Skip to main content
. 2020 Jul 13;2(8):1109–1119. doi: 10.1007/s42399-020-00364-3

Table 2.

The proportion of clinical manifestation differences between COVID-19 and dengue patients

No. Clinical manifestation COVID-19 Dengue infection
1. Fever

No specific fever patterns. Defervescence after 6 days of illness [33]

92.23–98.6% [3032]

Saddleback fever (fever with two peaks) [8]

100% [28, 29]

2 Headache 6.5–13.6% [30, 32, 35] 45–95% [8, 28]
3 Myalgia 15–44% [27, 3032] 12% [8]
4 Cough 76% [30] 21.5% [37]
5 Dyspnea 55% [30] 9.5–95.2% [38]
6 Diarrhea 2–34% [27, 3032] 6% [8]
7 Abdominal pain 2% [31, 32] 17–25% [28, 41]
8. Vomiting 4–5% [31, 32, 35] 30–58% [8, 41]
9 Cutaneous manifestation Erythematous rash, urticaria, chickenpox-like vesicles [66] Skin flushing that blanches on pressure, petechiae, and convalescent rash [8, 64]